Advisors Asset Management, Inc. Genmab A/S Transaction History

Advisors Asset Management, Inc.

$5.28 Billion
Q3 2024

A detailed history of Advisors Asset Management, Inc. transactions in Genmab A/S stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 6,219 shares of GMAB stock, worth $119,466. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,219

Previous 6,841 9.09%

Holding current value

$119,466

Previous $171,000 11.7%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$23.84 - $28.48 $14,828 - $17,714	-622 Reduced 9.09%	6,219 $151,000
Q2 2024 Aug 14, 2024	SELL	$25.13 - $30.27 $84,864 - $102,221	-3,377 Reduced 33.05%	6,841 $171,000
Q1 2024 May 14, 2024	SELL	$26.43 - $32.77 $60,366 - $74,846	-2,284 Reduced 18.27%	10,218 $305,000
Q4 2023 Feb 14, 2024	SELL	$27.94 - $35.44 $91,084 - $115,534	-3,260 Reduced 20.68%	12,502 $398,000
Q2 2023 Aug 14, 2023	SELL	$37.4 - $42.94 $112,050 - $128,648	-2,996 Reduced 15.97%	15,762 $599,000
Q1 2023 May 12, 2023	SELL	$34.88 - $43.22 $308,060 - $381,719	-8,832 Reduced 32.01%	18,758 $708,000
Q3 2022 Nov 08, 2022	SELL	$31.52 - $373.61 $210,994 - $2.5 Million	-6,694 Reduced 12.63%	46,327 $1.49 Million
Q2 2022 Aug 08, 2022	SELL	$26.83 - $38.57 $376,424 - $541,137	-14,030 Reduced 20.92%	53,021 $1.72 Million
Q1 2022 May 17, 2022	SELL	$30.95 - $39.68 $459,886 - $589,605	-14,859 Reduced 18.14%	67,051 $2.43 Million
Q4 2021 Feb 15, 2022	BUY	$35.87 - $47.12 $649,139 - $852,730	18,097 Added 28.36%	81,910 $3.24 Million
Q3 2021 Nov 12, 2021	BUY	$41.55 - $48.72 $657,445 - $770,896	15,823 Added 32.97%	63,813 $2.79 Million
Q2 2021 Jul 30, 2021	BUY	$32.88 - $44.57 $211,385 - $286,540	6,429 Added 15.47%	47,990 $1.96 Million
Q1 2021 May 07, 2021	BUY	$30.92 - $44.4 $495,709 - $711,820	16,032 Added 62.8%	41,561 $1.36 Million
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $401,395 - $486,063	11,925 Added 87.66%	25,529 $1.04 Million
Q3 2020 Nov 16, 2020	BUY	$33.07 - $38.68 $147,128 - $172,087	4,449 Added 48.6%	13,604 $498,000
Q2 2020 Aug 12, 2020	BUY	$20.05 - $33.89 $183,557 - $310,262	9,155 New	9,155 $310,000
Q1 2020 May 15, 2020	SELL	$17.15 - $25.22 $29,515 - $43,403	-1,721 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$18.88 - $24.14 $32,492 - $41,544	1,721 New	1,721 $38,000
Q2 2019 Aug 14, 2019	SELL	$16.37 - $18.47 $26,830 - $30,272	-1,639 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$14.53 - $17.93 $23,814 - $29,387	1,639 New	1,639 $29,000

Others Institutions Holding GMAB

# of Institutions

228

Shares Held

52.2M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $12.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Genmab A/S Transaction History